ACT-541468

CAS No. 1505484-82-1

ACT-541468( Nemorexant | ACT541468 | DORA )

Catalog No. M12099 CAS No. 1505484-82-1

A potent, selective, dual orexin receptor 1 and 2 (OX1 and OX2) antagonist with Kb of 0.52 and 0.78 nM, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    ACT-541468
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective, dual orexin receptor 1 and 2 (OX1 and OX2) antagonist with Kb of 0.52 and 0.78 nM, respectively.
  • Description
    A potent, selective, dual orexin receptor 1 and 2 (OX1 and OX2) antagonist with Kb of 0.52 and 0.78 nM, respectively; displays high selectivity over a panel of 130 central and peripheral pharmacological targets; shows potential for treatment of insomnia disorder.Sleep Disorder Phase 2 Clinical
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Nemorexant | ACT541468 | DORA
  • Pathway
    GPCR/G Protein
  • Target
    Orexin Receptor
  • Recptor
    Orexin Receptor
  • Research Area
    Neurological Disease
  • Indication
    Sleep Disorder

Chemical Information

  • CAS Number
    1505484-82-1
  • Formula Weight
    450.927
  • Molecular Formula
    C23H23ClN6O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 250 mg/mL 554.42 mM
  • SMILES
    O=C(N1[C@](C)(C2=NC3=C(C)C(Cl)=CC=C3N2)CCC1)C4=CC(OC)=CC=C4N5N=CC=N5
  • Chemical Name
    (S)-(2-(5-chloro-4-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Treiber A, et al. J Pharmacol Exp Ther. 2017 Sep;362(3):489-503.
molnova catalog
related products
  • Lemborexant

    An orally active, potent, selective, dual Orexin receptor OX1/2 antagonist with binding Ki of 6/3 nM, respectively.

  • Seltorexant

    A potent, selective, orally active orexin-2 receptor (OX2R) antagonist with pKi of 8.0 and 8.1 for human and rat OX2R, respectively.

  • SB-649868

    A potent, selective, orally bioavailable, dual orexin OX1/OX2R antagonist with pKi of 9.4 and 9.5 respectively.